In view of the remarkable in vitro effect of DLL4 in NOTCH1-mutated CLL, we sought to characterize which cells could express this ligand and trigger the activation of Notch in vivo. This evidence concerns the gene DLL4 and B-cell chronic lymphocytic leukemia.